Evaluation of result of Paribhdra & Amlaki kwath in Amlapitta(Hyperacidity) disease
- Conditions
- Other specified diseases of stomach and duodenum. Ayurveda Condition: AMLAPITTAM,
- Registration Number
- CTRI/2025/04/084669
- Lead Sponsor
- PGIA DSRRAU Jodhpur
- Brief Summary
My study titled **"Pharmacotherapeutical Evaluation of Paribhadra Patra and Amalaki Phala in the Management of Amlapitta (Hyperacidity)"** focuses on assessing the effectiveness of two traditional Ayurvedic remedies—**Paribhadra Patra** (leaves of Erythrina variegata) and **Amalaki Phala** (fruit of the Indian gooseberry)—in treating Amlapitta, commonly known as hyperacidity.
The research evaluates the pharmacological properties, therapeutic actions, and potential benefits of these remedies in alleviating symptoms such as indigestion, acidity, and gastritis. The study aims to provide scientific evidence supporting their use in managing hyperacidity and offers insights into their mechanisms of action, dosage, and safety profile in the context of Ayurvedic treatment practices.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 30
Clinically and pathologically diagnosed patient , who are suffering from Amlapitta.
- Subject should not suffering from Amlapitta more than 3 months 2.
- Age below 16 years and above 50 years 3.
- Subject reporting with complication like cardiac problem , emphysema, carcinoma etc.
- will be excluded 4.
- Pregnant woman and lactating mothers was excluded 5.
- Subject with gastric malignancy 6.
- Subject who recently undergo gastro-intestinal surgery.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in the objective parameters 1 month
- Secondary Outcome Measures
Name Time Method Changes in the clinical sign and symptoms of Amlapitta 1 month
Trial Locations
- Locations (1)
Sanjeevani Hospital
🇮🇳Jodhpur, RAJASTHAN, India
Sanjeevani Hospital🇮🇳Jodhpur, RAJASTHAN, IndiaDr Kalpana PooniaPrincipal investigator8824705009kalpana0210poonia@gmail.com